These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11267195)

  • 1. Acute rejection after liver transplantation despite intragraft coating by interleukin-2 receptor-alpha with basiliximab.
    Kwekkeboom J; Maas M; Rietveld JH; Zondervan PE; Bouma GJ; Tilanus HW; Metselaar HJ
    Transplant Proc; 2001; 33(1-2):1071-3. PubMed ID: 11267195
    [No Abstract]   [Full Text] [Related]  

  • 2. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
    Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of newer monoclonal antibodies in renal transplantation.
    Vincenti F
    Transplant Proc; 2001; 33(1-2):1000-1. PubMed ID: 11267163
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of anti-interleukin-2 receptor antibodies in pediatric liver transplantation.
    Kelly DA
    Pediatr Transplant; 2001 Dec; 5(6):386-9. PubMed ID: 11737761
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-interleukin-2 receptor antibodies: basiliximab and daclizumab.
    Pascual J; Marcén R; Ortuño J
    Nephrol Dial Transplant; 2001 Sep; 16(9):1756-60. PubMed ID: 11522853
    [No Abstract]   [Full Text] [Related]  

  • 7. Basiliximab decreases the incidence of acute rejection after intestinal transplantation.
    Sudan DL; Chinnakotla S; Horslen S; Iyer K; Fox I; Shaw B; Langnas AN
    Transplant Proc; 2002 May; 34(3):940-1. PubMed ID: 12034250
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockade of intragraft IL-2 receptor-alpha by basiliximab is insufficient to prevent activation of liver graft infiltrating cells.
    Kwekkeboom J; Warlé MC; Rietveld J; Segeren KC; Tilanus HW; Metselaar HJ
    Transpl Immunol; 2003; 11(1):1-5. PubMed ID: 12727469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study.
    Gibelli NE; Pinho-Apezzato ML; Miyatani HT; Maksoud-Filho JG; Silva MM; Ayoub AA; Santos MM; Velhote MC; Tannuri U; Maksoud JG
    Transplant Proc; 2004 May; 36(4):956-7. PubMed ID: 15194332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with basiliximab in pediatric liver graft recipients.
    Ganschow R; Lyons M; Grabhorn E; Venzke A; Broering DC; Rogiers X; Hellwege HH; Burdelski M
    Transplant Proc; 2001; 33(7-8):3606-7. PubMed ID: 11750532
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
    Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basiliximab reduces acute liver allograft rejection in pediatric patients.
    Strassburg A; Pfister ED; Arning A; Nashan B; Ehrich JH; Melter M
    Transplant Proc; 2002 Sep; 34(6):2374-5. PubMed ID: 12270443
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM; Lohmann R; Guckelberger O; Müller AR; Raakow R; Nüssler NC; Klupp J; Pfitzmann R; Jonas S; Settmacher U; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
    Kahan BD; Rajagopalan PR; Hall M
    Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A
    Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First experience with basiliximab in pediatric liver graft recipients.
    Ganschow R; Broering DC; Stuerenburg I; Rogiers X; Hellwege HH; Burdelski M
    Pediatr Transplant; 2001 Oct; 5(5):353-8. PubMed ID: 11560755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
    Orr DW; Portmann BC; Knisely AS; Stoll S; Rela M; Muiesan P; Bowles MJ; Heaton ND; O'Grady JG; Heneghan MA
    Transplant Proc; 2005 Dec; 37(10):4373-9. PubMed ID: 16387124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber AO
    Transplant Proc; 2001; 33(1-2):1701-3. PubMed ID: 11267477
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
    Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimarães S
    Transplant Proc; 2000 Dec; 32(8):2623-5. PubMed ID: 11134730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.